Fluence Energy, AGL sign deal to deliver 500MW/2000MWh Tomago battery system
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 days ago
- Yahoo
Fluence Energy (FLNC) Q2 Earnings Report Preview: What To Look For
Electricity storage and software provider Fluence (NASDAQ:FLNC) will be reporting results this Monday after market hours. Here's what investors should know. Fluence Energy beat analysts' revenue expectations by 29.8% last quarter, reporting revenues of $431.6 million, down 30.7% year on year. It was a slower quarter for the company, with full-year revenue guidance missing analysts' expectations significantly and full-year EBITDA guidance missing analysts' expectations significantly. It reported 19,900 deployed megawatts for digital contracts, up 15.7% year on year. Is Fluence Energy a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Fluence Energy's revenue to grow 57.9% year on year to $763.4 million, a reversal from the 9.9% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.01 per share. Heading into earnings, analysts covering the company have grown increasingly bearish with revenue estimates seeing 5 downward revisions over the last 30 days (we track 15 analysts). Fluence Energy has missed Wall Street's revenue estimates four times over the last two years. Looking at Fluence Energy's peers in the renewable energy segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Generac delivered year-on-year revenue growth of 6.3%, beating analysts' expectations by 3.4%, and Sunrun reported revenues up 8.7%, topping estimates by 4%. Generac traded up 28.9% following the results while Sunrun was also up 16.5%. Read our full analysis of Generac's results here and Sunrun's results here. Investors in the renewable energy segment have had steady hands going into earnings, with share prices flat over the last month. Fluence Energy is up 1.4% during the same time and is heading into earnings with an average analyst price target of $8.74 (compared to the current share price of $8.29). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Yahoo
Fluence Energy (FLNC) Q2 Earnings Report Preview: What To Look For
Electricity storage and software provider Fluence (NASDAQ:FLNC) will be reporting results this Monday after market hours. Here's what investors should know. Fluence Energy beat analysts' revenue expectations by 29.8% last quarter, reporting revenues of $431.6 million, down 30.7% year on year. It was a slower quarter for the company, with full-year revenue guidance missing analysts' expectations significantly and full-year EBITDA guidance missing analysts' expectations significantly. It reported 19,900 deployed megawatts for digital contracts, up 15.7% year on year. Is Fluence Energy a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Fluence Energy's revenue to grow 57.9% year on year to $763.4 million, a reversal from the 9.9% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.01 per share. Heading into earnings, analysts covering the company have grown increasingly bearish with revenue estimates seeing 5 downward revisions over the last 30 days (we track 15 analysts). Fluence Energy has missed Wall Street's revenue estimates four times over the last two years. Looking at Fluence Energy's peers in the renewable energy segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Generac delivered year-on-year revenue growth of 6.3%, beating analysts' expectations by 3.4%, and Sunrun reported revenues up 8.7%, topping estimates by 4%. Generac traded up 28.9% following the results while Sunrun was also up 16.5%. Read our full analysis of Generac's results here and Sunrun's results here. Investors in the renewable energy segment have had steady hands going into earnings, with share prices flat over the last month. Fluence Energy is up 1.4% during the same time and is heading into earnings with an average analyst price target of $8.74 (compared to the current share price of $8.29). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Yahoo
05-08-2025
- Yahoo
Here's What Key Metrics Tell Us About Agilon (AGL) Q2 Earnings
Agilon Health (AGL) reported $1.39 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 5.9%. EPS of -$0.25 for the same period compares to -$0.07 a year ago. The reported revenue represents a surprise of -4.98% over the Zacks Consensus Estimate of $1.47 billion. With the consensus EPS estimate being -$0.11, the EPS surprise was -127.27%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how Agilon performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Avg. Medicare Advantage Members: 498,000 compared to the 493,100 average estimate based on two analysts. Revenues- Other operating: $2.94 million versus $3.16 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -7.4% change. Revenues- Medical services: $1.39 billion compared to the $1.46 billion average estimate based on five analysts. The reported number represents a change of -5.9% year over year. View all Key Company Metrics for Agilon here>>> Shares of Agilon have returned -30% over the past month versus the Zacks S&P 500 composite's +0.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Agilon Health, Inc. (AGL) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
